PERBANDINGAN NILAI INDEKS CASTELLI RISK II PADA FAKTOR RESIKO STROKE ISKEMIK SERANGAN PERTAMA

  • Zenine Charolin Sinulingga Fakultas Kedokteran Universitas Kristen Duta Wacana
  • Rizaldy Taslim Pinzon
  • Loury Priskila Fakultas Kedokteran Universitas Kristen Duta Wacana Yogyakarta
  • MMA Dewi Lestari Universitas Kristen Duta Wacana
Keywords: ischemic stroke, Castelli Risk Index II, LDL, HDL, Hyperlipidemia

Abstract

Background: Ischemic stroke is the most common type of stroke and a leading cause of disability and death. One of its major risk factors is dyslipidemia, which can be assessed using the Castelli Risk Index II (CRI-II), calculated as the ratio of LDL to HDL. A high CRI-II indicates increased atherogenic potential and a higher likelihood of stroke occurrence, particularly the first event.

Objective: This study aims to determine the comparison of CRI-II values based on ischemic stroke risk factors such as hypertension, age, sex, diabetes mellitus, smoking status, and lipid profiles in patients with first-onset ischemic stroke.

Methods: This was a descriptive analytic study using a cross-sectional approach and secondary data from 120 ischemic stroke patients aged 40–59 years across several hospitals in Yogyakarta. Data analysis was conducted using the Kolmogorov-Smirnov normality test and the chi-square test to assess relationships between variables.

Results: Most patients (55%) had high CRI-II values (>3.5). No significant differences in CRI-II were found based on hypertension, age, sex, smoking status, or history of diabetes mellitus. However, there was a significant association between high LDL levels and CRI-II values (p=0.001), indicating the dominant role of LDL in increasing atherosclerotic risk, as LDL is directly involved in the CRI-II calculation.

Conclusion: There were no significant differences in CRI-II values across most analyzed risk factors, except for LDL levels. This highlights the importance of lipid control, especially LDL, in preventing first-time ischemic stroke.

References

Abdu, H., & Seyoum, G. (2022). Sex Differences in Stroke Risk Factors, Clinical Profiles, and In- Hospital Outcomes Among Stroke Patients Admitted to the Medical Ward of Dessie Comprehensive Specialized Hospital, Northeast Ethiopia. Degenerative neurological and neuromuscular disease, 12, 133–144.https://doi.org/10.2147/DNND.S 383564

Amarenco, P.,et al. 2018. Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke. N Engl J Med. https://doi.org/10.1056/nejmoa18 02712

Aroor, S., Singh, R., & Goldstein, L. B. (2017). BE-FAST (Balance,Eyes, Face, Arm, Speech, Time). In Stroke (Vol. 48, Issue 2, pp. 479–481). Ovid Technologies (Wolters Kluwer Health).https://doi.org/10.1161/strokeaha.116.015169

Arumugham VB, Shahin MH. Therapeutic Uses of Diuretic Agents. [Updated 2023 May 29]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/bo oks/NBK557838/

Baba M, Maris M, Jianu D, Luca CT, Stoian D, Mozos I. The Impact of the Blood Lipids Levels on Arterial Stiffness. J Cardiovasc Dev Dis. 2023 Mar 16;10(3):127.

doi: 10.3390/jcdd10030127. PMID: 36975891; PMCID: PMC10056627.

Batubo, N. P., Auma, C. I., Moore, J. B., & Zulyniak, M. A. (2025). Evaluating modifiable hypertension risk in Nigerian adults-The Nigerian diet risk score. Tropical medicine & international health : TM & IH, 30(4),260–272.https://doi.org/10.1111/tmi.1408 9

Boehme AK, Esenwa C, Elkind MS. Stroke Risk Factors, Genetics, and Prevention. Circ Res. 2017 Feb 3;120(3):472-495. doi: 10.1161/CIRCRESAHA.116.308398. PMID: 28154098; PMCID: PMC5321635.

Burger, P. M., Dorresteijn, J. A. N., Koudstaal, S., Holtrop, J., Kastelein, J. J. P., Jukema, J. W., Ridker, P. M., Mosterd, A., & Visseren, F. L. J. (2024). Course of the effects of LDL-cholesterol reduction on cardiovascular risk over time: A meta-analysis of 60 randomized controlled trials. Atherosclerosis, 396, 118540. https://doi.org/10.1016/j.atherosc lerosis.2024.118540

Chiesa, S.T., Charakida, M. High- Density Lipoprotein Function and Dysfunction in Health and Disease. Cardiovasc Drugs Ther 33, 207–219 (2019).https://doi.org/10.1007/s10557- 018-06846-w

ChughC. Acute Ischemic Stroke: Management Approach. Indian J Crit Care Med. 2019 Jun;23(Suppl 2):S140-S146. doi: 10.5005/jp-journals-10071- 23192. PMID: 31485123; PMCID: PMC6707502.

Darmawati, Annisa; Prasetyo, Sabarinah; and Najah, Miftahun (2024) "Stroke pada Lansia di Indonesia: Gambaran Faktor Risiko Berdasarkan Gender (SKI 2023)," Jurnal Biostatistik, Kependudukan, dan Informatika Kesehatan: Vol. 5: No. 1, Article4. DOI:10.7454/bikfokes.v5i1.1092 Available at: https://scholarhub.ui.ac.id/bikfok es/vol5/iss1/4

Dharmaraj S, Rajaragupathy S, Denishya S. A Descriptive Study of Atherogenic Indices in Patients Admitted to a Tertiary Care Hospital. Cureus. 2022 Dec 5;14(12):e32231. doi:10.7759/cureus.32231. PMID: 36620793; PMCID: PMC9812546.

Dib, M. J., Zagkos, L., Meena, D., Burgess, S., Chirinos, J. A., & Gill, D. (2024). LDL-c Lowering, Ischemic Stroke, and Small Vessel Disease Brain Imaging Biomarkers: A Mendelian Randomization Study. Stroke, 55(6), 1676–1679. https://doi.org/10.1161/STROKE AHA.123.045297

Ding, P. F., Zhang, H. S., Wang, J., Gao, Y. Y., Mao, J. N., Hang, C. H., & Li, W. (2022). Insulin resistance in ischemic stroke: Mechanisms and therapeutic approaches. Frontiers in endocrinology, 13, 1092431.https://doi.org/10.3389/fendo.202 2.1092431

Du, M., Mi, D., Liu, M. and Liu, J., 2023. Global trends and regional differences in disease burden of stroke among children: a trend analysis based on the global burden of disease study 2019. BMC Public Health, https://doi.org/10.1186/s12889- 023-17046-z

El Khoudary, S. R., Aggarwal, B., Beckie, T. M., Hodis, H. N., Johnson, A. E., Langer, R. D.,

Limacher, M. C., Manson, J. E., Stefanick, M. L., & Allison, M. A. (2020). Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention: A Scientific Statement From the American Heart Association. In Circulation (Vol. 142, Issue 25). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1161/cir.00000 00000000912

European Society of Cardiology. (2020). High-density lipoprotein cholesterol and risk of cardiovascular disease. E- Journal of Cardiology Practice, 19. Diakses dari https://www.escardio.org/Journal s/E-Journal-of-Cardiology- Practice/Volume-19/high- density-lipoprotein-cholesterol- and-risk-of-cardiovascular- disease

European Society of Cardiology. (2021). HDL Cholesterol, LDL Cholesterol, and Coronary Atherosclerosis. European Association of Preventive Cardiology (EAPC). Diakses dari https://www.escardio.org/Sub- specialty-

communities/European- Association-of-Preventive- Cardiology-(EAPC)/News/hdl- cholesterol-ldl-cholesterol-and- coronary-atherosclerosis

Fauzi, A., Rizqiya, S., Muharrika, Z., & Syukriyah, D. (2024). Hypertension as a risk factor in stroke: An overview. World Journal Of Advanced Research and Reviews.

https://doi.org/10.30574/wjarr.20 24.21.1.0204

Fauzani, Huriyah & Yaswir, Rismawati & Rasyid, Rosfita. (2022). Gambaran Castelli’s Risk Index- 2 pada Pasien Sindrom Koroner Akut di RSUP Dr. M. Djamil Padang. Jurnal Ilmu Kesehatan Indonesia. 2. 218-223. 10.25077/jikesi.v2i4.254.

Febriana, S., & Ardhi, M. S. (2021). Atherogenic Index Profile on Ischemic Stroke Patients at Neurology Department, Dr. Soetomo Surabaya: A Retrospective Study. In International Journal of Research and Review (Vol. 8, Issue 11, pp. 332–336). Galore Knowledge Publication Pvt. Ltd. https://doi.org/10.52403/ijrr.2021 1141

Feigin, V. L., et al (2021). Global, regional, and national burden of stroke and its risk factors, 1990– 2019: a systematic analysis for the Global Burden of Disease Study 2019. In The Lancet Neurology (Vol. 20, Issue 10, pp.

–820). Elsevier BV. https://doi.org/10.1016/s1474- 4422(21)00252-0

Feingold KR. Introduction to Lipids and Lipoproteins. [Updated 2024 Jan 14]. In: Feingold KR, Ahmed SF, Anawalt B, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/bo oks/NBK305896/

Feingold KR. Guidelines for the Management of High Blood Cholesterol. [Updated 2025 Mar 27]. In: Feingold KR, Ahmed SF, Anawalt B, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/bo oks/NBK305897/

Gaggini, M.; Gorini, F.; Vassalle, C. Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with

Hyperlipidemia. Int. J. Mol. Sci. 2023, 24, 75.

https://doi.org/10.3390/ijms2401 0075

Guo, J., Wang, A., Wang, Y., Liu, X., Zhang, X., Wu, S., & Zhao, X. (2021). Non-traditional Lipid Parameters as Potential Predictors of Asymptomatic Intracranial Arterial Stenosis. Frontiers in Neurology, 12.

https://doi.org/10.3389/fneur.202 1.679415

Gowda, Yashwanth & N, Asha & Nusrath, Aliya & Ningappa, Asharani. (2020). Atherogenic Predictor Indices: Role in Assessment of Cardiovascular Risk in Type 2 Diabetes Mellitus. 5. 36-41. 10.9790/264X-0504023641.

Grundy, S. M., et al. (2019). 2018 AHA/ACC/AACVPR/AAPA/ABC/ ACPM/ADA/AGS/APhA/ASPC/N

LA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 139(25), e1082- e1143.

Guo, J., Wang, A., Wang, Y., Liu, X., Zhang, X., Wu, S., & Zhao, X. (2021). Non-traditional Lipid Parameters as Potential Predictors of Asymptomatic Intracranial Arterial Stenosis. In Frontiers in Neurology (Vol. 12). Frontiers Media SA. https://doi.org/10.3389/fneur.202 1.679415

Hastrup, S., Hedegaard, J. N., Andersen, G., Rungby, J., & Johnsen, S. P. (2024). Type 2 diabetes mellitus in patients with ischemic stroke - A nationwide study. Diabetic medicine : a journal of the British Diabetic Association, 41(8), e15337.https://doi.org/10.1111/dme.1533 7

Holven, K. B., & Roeters van Lennep, J. (2023). Sex differences in lipids: A life course approach. Atherosclerosis, 384, 117270. https://doi.org/10.1016/j.atherosc lerosis.2023.117270

Howard, G., Muntner, P., Lackland, D. T., Plante, T. B., Cushman, M.,Stamm, B., Judd, S. E., & Howard, V. J. (2025).Association of Duration of Recognized Hypertension and Stroke Risk: The REGARDS Study. Stroke, 56(1), 105–112. https://doi.org/10.1161/STROKE AHA.124.048385

Huang, Y., Wang, J., & Zhang, L. (2021). Hypertension and Its Impact on Cardiovascular Health: A Review. Journal of Hypertension Research, 37(3),145-156.

Imannezhad, M., Kamrani, F., Shariatikia, A. et al. Association of atherogenic indices and triglyceride-total cholesterol- body weight index (TCBI) with severity of stenosis in patients undergoing angiography: a case- control study. BMC Res Notes 18, 180 (2025).https://doi.org/10.1186/s13104- 025-07203-5

Jiang, Y., Zhang, L. & Gu, Z. LDL- C/HDL-C ratio as a predictor of atherosclerosis in the Japanese population: insights from a cross- sectional study. BMC Cardiovasc Disord 25, 333 (2025).https://doi.org/10.1186/s12872- 025-04792-8

Jha, Birendra. (2024). Atherogenic Index of Plasma and its Correlations to Cardiovascular Risk Factors among Obese Adults in Nepal. Biomedical Journal of Scientific & Technical Research. 58. 10.26717/BJSTR.2024.58.00914

Joundi, R. A., Patten, S. B., Williams, J. V., & Smith, E. E. (2022). Vascular risk factors and stroke risk across the life span: A population-representative study of half a million people. International journal of stroke : official journal of the International Stroke Society, 17(9), 1021–1029.

https://doi.org/10.1177/17474930 211070682

Kleindorfer, D. O., et al (2021). 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke, 52(7), e364-e467.

Kuriakose, D., Xiao, Z., 2020. Pathophysiology and Treatment of Stroke: Present Status and Future Perspectives. IJMS. https://doi.org/10.3390/ijms2120 7609

Lai W, Chen X, Wang L, Wu L, Li X and Zhou B (2025) Association between LDL/HDL ratio and hypertension in Chinese middle- aged and older adults: a cross- sectional and longitudinal analysis based on CHARLS LDL/HDL ration and hypertension. Front. Endocrinol. 16:1484318.https://doi.org/10.3389/fendo.202 5.1484318

Li, Y., Feng, Y., Li, S., Ma, Y., Lin, J.,Wan, J., & Zhao, M. (2023). The atherogenic index of plasma (AIP) is a predictor for the severity of coronary artery disease. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.202 3.1140215

Liu, S., & Chen, X. (2022).Atherosclerosis: Pathophysiology and Management Strategies. Cardiovascular Medicine, 28(2),98-110.

Lumu W, Bahendeka S, Wesonga R, Kibirige D, Kasoma RM, Ssendikwanawa E. Atherogenic index of plasma and its cardiovascular risk factor correlates among patients with type 2 diabetes in Uganda. Afr Health Sci. 2023

Mar;23(1):515-527. doi: 10.4314/ahs.v23i1.54.PMID: 37545918; PMCID: PMC10398456

Ma, Z., He, W., Zhou, Y. et al. Global burden of stroke in adolescents and young adults (aged 15–39 years) from 1990 to 2019: a comprehensive trend analysis based on the global burden of disease study 2019. BMC Public Health 24, 2042 (2024).https://doi.org/10.1186/s12889- 024-19551-1

Mahdavi-Roshan, M., Mozafarihashjin, M., Shoaibinobarian, N., Ghorbani, Z., Salari, A., Savarrakhsh, A., & Hekmatdoost, A. (2022). Evaluating the use of novel atherogenicity indices and insulin resistance surrogate markers in predicting the risk of coronary artery disease: a case‒control investigation with comparison to traditional biomarkers. Lipids in health and disease, 21(1), 126. https://doi.org/10.1186/s12944- 022-01732-9

Momayyezi, M., Jambarsang, S., Fallahzadeh, H. et al. Association between lipid profiles and cigarette smoke among adults in the Persian cohort (Shahedieh) study. BMC Public Health 24, 1256 (2024). https://doi.org/10.1186/s12889- 024-18734-0

Nakamura, M., Yamamoto, Y., Imaoka, W., Kuroshima, T., Toragai, R.,Ito, Y., Kanda, E., J Schaefer, E., & Ai, M. (2021). Relationships between Smoking Status, Cardiovascular Risk Factors, and Lipoproteins in a Large Japanese Population. Journal of atherosclerosis and thrombosis, 28(9), 942–953.https://doi.org/10.5551/jat.56838 Ojo, D.T., Brewer, P.C., Imeh-Nathaniel,A. et al. Sex differences in clinical risk factors in obese ischemic stroke patients with a history of smoking. BMC Cardiovasc Disord 24, 288(2024).https://doi.org/10.1186/s12872- 024-03952-6

Parmar, M. P., Kaur, M., Bhavanam, S.,Mulaka, G. S. R., Ishfaq, L.,Vempati, R., C, M. F., Kandepi,H. V., Er, R., Sahu, S., & Davalgi, S. (2023). A Systematic Review of the Effects of Smoking on the Cardiovascular System and General Health. Cureus, 15(4), e38073. https://doi.org/10.7759/cureus.38 073

Pickham D, Valdez A, Demeestere J, Lemmens R, Diaz L, Hopper S, de la Cuesta K, Rackover F, Miller K, Lansberg MG. Prognostic Value of BEFAST vs. FAST to Identify Stroke in a Prehospital Setting. Prehosp Emerg Care. 2019 Mar- Apr;23(2):195-200. doi: 10.1080/10903127.2018.1490837. Epub 2018 Aug 23. PMID:30118372.

Powers, W. J., Rabinstein, A. A., Ackerson, T., et al. (2018). 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart

Association/American Stroke Association. Stroke, 49(3), e46– e99. DOI:10.1161/STR.0000000000000158.

Prakoso, R. A. P., Ardhi, M. S. ., Thamrin, H. ., & Setyowatie, S. . (2025). Epidemiologic Profile of Ischemic Stroke Patients with Dyslipidemia in Dr. Soetomo General Academic Hospital Patient. AKSONA, 5(1), 12–17.

https://doi.org/10.20473/aksona.v 5i1.64275

Puspa, Niken & Lestari, Dina & Kaniawati, Sofie. (2022). a Comparison of Lipid Profile in Ischemic Stroke Patiens with Diabetes Mellitus and Non- Diabetes Mellitus at Rumah Sakit Umum Daerah Ciamis 2020. Jurnal Profesi Medika : Jurnal Kedokteran dan Kesehatan. 16.10.33533/jpm.v16i2.4809

Qin, H., Yang, F., Zhao, H., Zhao, J.,Lin, S., Shang, Y., Zhang, C.,Hao, P., & Zhang, X. (2023). Associations of lipids and lipid- lowering drugs with risk of stroke: a Mendelian randomization study. In Frontiers in Neurology (Vol. 14). Frontiers Media SA.https://doi.org/10.3389/fneur.202 3.1185986

Rissanen, I., Basten, M., Exalto, L.G. et al. Sex differences in modifiable risk factors for stroke incidence and recurrence: the UCC- SMART study. J Neurol 271, 3347–3358 (2024).https://doi.org/10.1007/s00415- 024-12268-6

Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., ... & GBD-

NHLBI-JACC Global Burden of Cardiovascular Diseases Writing Group. (2020). Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study. Journal of the American College of Cardiology, 76(25), 2982-3021.

Sabih A, Tadi P, Kumar A. Stroke Prevention. [Updated 2023 Jun 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/bo oks/NBK470234/

Setyopranoto, I., Bayuangga, H. F., Panggabean, A. S., Alifaningdyah, S., Lazuardi, L., Sutarni, S., & Wijayanti, M. A. (2019). Prevalence of stroke and associated risk factors in Sleman District of Yogyakarta Special Region, Indonesia. Stroke Research and Treatment, 2019, 2642458.

Syukriyah, Sarah & al Fauzi, Asra. (2024). Hypertension as a risk factor in stroke: An overview. World Journal of Advanced Research and Reviews. 21. 2370-2372.10.30574/wjarr.2024.21.1.0204

Tabassum, R., Ruotsalainen, S., Ottensmann, L., Gerl, M. J., Klose, C., Tukiainen, T., Pirinen, M., Simons, K., Widén, E., & Ripatti, S. (2022). Lipidome- and Genome-Wide Study to Understand Sex Differences in Circulatory Lipids. Journal of the American Heart Association, 11(19), e027103.https://doi.org/10.1161/JAHA.12 2.027103

Tortora, G. J., & Derrickson, B. (2022). Principles of Anatomy and Physiology (16th ed.). Wiley.

Venketasubramanian N, Yudiarto FL, Tugasworo D. Stroke Burden and Stroke Services in Indonesia. Cerebrovasc Dis Extra. 2022;12(1):53-57. doi:10.1159/000524161. Epub 2022 Mar 21. PMID: 35313314; PMCID: PMC9149342.

Wang, X., Wu, L., Shu, P., Yu, W., & Yu, W. (2024). Significant association between three atherosclerosis indexes and stroke risk. PloS one, 19(12),e0315396.https://doi.org/10.1371/journal.p one.0315396W medicine, 9,948707.https://doi.org/10.3389/fcvm.202 2.948707

Wu J, Zhou Q, Wei Z, Wei J and Cui M (2021) Atherogenic Index of Plasma and Coronary Artery Disease in the Adult Population: A Meta-Analysis. Front. Cardiovasc. Med. 8:817441. doi:10.3389/fcvm.2021.81744

Xie F, Li X, Xu Y, Cheng D, Xia X, Lv X, Yuan G and Peng C (2022) Estrogen Mediates an Atherosclerotic-Protective Action via Estrogen Receptor Alpha/SREBP-1 Signaling. Front. Cardiovasc. Med. 9:895916. doi:10.3389/fcvm.2022.895916

Xie, Z. L., Wang, C. C., Huang, X., Wang, Z., Shangguan, H. Y., & Wang, S. H. (2024). Prevalence and Risk Factors of Stroke in Inpatients with Type 2 Diabetes Mellitus in China. Current medical science, 44(4), 698–706. https://doi.org/10.1007/s11596- 024-2911-1

Yousufuddin, M., & Young, N. (2019). Aging and ischemic stroke. Aging, 11(9), 2542–2544.

https://doi.org/10.18632/aging.10 1931

Zhang, X. X., Wei, M., Shang, L. X., Lu,Y. M., Zhang, L., Li, Y. D.,Zhang, J. H., Xing, Q., Tu-Erhong, Z. K., Tang, B. P., &

Zhou, X. H. (2020). LDL-C/HDL-C is associated with ischaemic stroke in patients with non-valvular atrial fibrillation: a case-control study. Lipids in health and disease, 19(1), 217. https://doi.org/10.1186/s12944- 020-01392-7

Zheng, Y., Gao, X., Jia, H. Y., Li, F. R.,& Ye, H. (2022). Influence of hypertension duration and blood pressure levels on cardiovascular disease and all-cause mortality: A large prospective cohort study. Frontiers in cardiovascular

Published
2026-01-21

Most read articles by the same author(s)

Obs.: This plugin requires at least one statistics/report plugin to be enabled. If your statistics plugins provide more than one metric then please also select a main metric on the admin's site settings page and/or on the journal manager's settings pages.